CLINICAL_TRIALS
research
· 2020-09-24
Clinical Trial Update: LUME BioNIS: a Biomarker Study in Patients With NSCLC
Summary
A completed biomarker study in patients with non-small cell lung carcinoma (NSCLC).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED | Results posted: 2020-09-24